LONDON, March 19, 2018 /PRNewswire/ — Smith & Nephew (NYSE: SNN; LSE:SN), the global medical technology business, today announces the donation of more than $3M of trauma plates and screws, external fixation implants and instruments to The Podiatry Institute (PI). This equipment will be used to support ongoing educational courses conducted at the PI through the American Academy of Foot and Ankle Osteosynthesis (AAFAO).
Smith & Nephew has been the sole sponsor of the comprehensive and advanced educational courses conducted by the PI and AAFAO for the past four years, contributing to resident education for nearly 1600 participants. The company not only provided the surgical equipment and personnel support for these courses, but also hosted the event at its world class Innovation Center in Memphis, Tenn.
“Smith & Nephew has always been proud to support this important training. We view this donation as an important business need for podiatric resident training and their future patients,” said John Clausen, Vice President Global Marketing, Trauma and Extremities. “Along with this donation of surgical equipment, we will also continue to provide support with the appropriate Smith & Nephew personnel.”
The AAFAO was founded in 2014 for the sole purpose of training podiatric residents in the techniques and skills of skeletal fixation, trauma and reconstructive surgery of the foot and ankle. Courses are led by some of the best podiatrists in the profession with curriculum covering application of the principles and techniques for current and novel approaches to reconstructive surgery on the foot and ankle. This donation allows the AAFAO and PI to host these courses multiple times a year while opening up opportunities for multiple sponsors.
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2017 were almost $4.billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as “aim”, “plan”, “intend”, “anticipate”, “well-placed”, “believe”, “estimate”, “expect”, “target”, “consider” and similar expressions are generally intended to identify forward- looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew’s most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew’s expectations.
™ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.
SOURCE Smith & Nephew